...
首页> 外文期刊>Journal of Drug Delivery and Therapeutics >Clinical Endpoint: Substitute for Prediction of Clinical Benefit
【24h】

Clinical Endpoint: Substitute for Prediction of Clinical Benefit

机译:

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

An endpoint is a primary or secondary outcome used to judge the effectiveness of a treatment; it is a precisely defined variable intended to reflect an outcome of interest thatis statistically analyzed. An endpoint usually specifies the sort of assessments made, the timing of those assessments, the assessment tools used and possibly other details, as applicable, such as how multiple assessments within an individual are to be combined. There are different types of endpoints used in clinical trails like primary endpoint, secondary endpoint, multiple endpoint and surrogate endpoint. Primary endpoint means the outcome or event that most accurately measures the benefit of the therapy or drug being studied and this is the most clinically important endpoint. Secondary endpoints are related to toxicity and undesired effects of the new therapy to demonstrate additional effects on the disease or condition. Multiple endpoint is useful in determining clinical advantage of drug depending on one illness side. A surrogate endpoint is a laboratory measure or a physical sign supposed to be used as a substitute for a clinically meaningful endpoint which in all fairness possible to predict clinical benefit.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号